全球脑保健补充剂市场：市场规模和占有率分析 - 趋势、驱动因素、竞争格局和预测（2024-2030）

市场概况

预计2023年全球脑保健补充品市场规模将达92.382亿美元，2030年将达161.139亿美元，2024年至2030年复合年增长率为8.4%。随着人们认识到这是一种必需品，对用于增强注意力、记忆力和控制压力（尤其是老年人）的各种保健补充剂的需求正在增加，从而推动了市场成长。

重要见解

预测期内，草药萃取物类别（银杏、姜黄素、人参、绿茶萃取物等）预计将以 8.7% 的复合年增长率成长。在中国和印度等新兴国家，对草药产品的需求正在增加。

天然分子品类将在2023年位居第二，占全球收入的55%。与合成补充剂相比，对非合成补充剂的需求不断增长。由于消费者的压力，公司正在转向将天然成分融入产品中。

2023 年，记忆体增强类别产生了最大的收入占有率，约 30%。同时，成长第二快的类别是压力和焦虑。

2023年，北美地区的产业占有率为50%。这是由于人们对认知健康的兴趣增加和体育部门的蓬勃发展。此外，在大脑健康问题、教育领域的压力和需求的推动下，亚太地区预计将成长 9.0% 以上。

本报告分析了全球脑保健补充剂市场，包括市场的基本结构、最新情况、主要促进和抑制因素以及全球、依地区和主要国家的市场规模前景（基于价值，来自2017 年起），2030 年） ，依产品和应用划分的详细趋势、市场竞争现状以及主要公司概况。

目录

第一章 调查范围

第二章 研究方法

第三章执行摘要

第四章 市场指标

第五章 产业展望

• 市场动态
  • 趋势
  • 促进因素
  • 抑制因素/课题
  • 促进/抑制因素影响分析
• 新型冠状病毒感染（COVID-19）的影响
• 波特五力分析

第六章 世界市场

• 概述
• 市场收入：依产品分类（2017-2030）
• 市场收入：依应用分类（2017-2030）
• 市场收入：依地区（2017-2030）

第七章 北美市场

• 概述
• 市场收入：依产品分类（2017-2030）
• 市场收入：依应用分类（2017-2030）
• 市场收入：依国家分类（2017-2030）

第八章欧洲市场

第九章亚太市场

第十章 拉丁美洲市场

第十一章 中东/非洲市场

第十二章 美国市场

• 概述
• 市场收入：依产品分类（2017-2030）
• 市场收入：依应用分类（2017-2030）

第十三章 加拿大市场

第十四章 德国市场

第十五章 法国市场

第十六章 英国市场

第十七章 义大利市场

第十八章 西班牙市场

第十九章 日本市场

第20章 中国市场

第21章 印度市场

第22章澳洲市场

第23章 韩国市场

第24章 巴西市场

第25章 墨西哥市场

第26章 沙乌地阿拉伯市场

第27章南非市场

第28章 阿拉伯联合大公国（UAE）市场

第29章竞争格局

• 市场参与者及其产品清单
• 主要企业竞争基准
• 主要公司的产品基准
• 近期策略发展

第三十章 公司简介

• AlternaScript LLC
• Natrol LLC
• Health Via Modern Nutrition Inc.
• KeyView Labs Inc.
• Natural Factors Nutritional Products Ltd.
• Onnit Labs Inc.
• Peak Nootropics LLC
• Purelife Bioscience Co. Ltd.
• Intelligent Labs
• Accelerated Intelligence Inc.
• NOW Foods

第31章附录

Market Overview

The global brain health supplements market size was USD 9,238.2 million in 2023, and it is expected to reach USD 16,113.9 million by 2030, advancing with a CAGR of 8.4% during 2024-2030. As people realize this as a necessity, increasing demand for various health supplements used for attention and memory enhancement and to manage stress (especially in the elderly) is pushing the market growth.

However, beliefs matter in the layout of food and vitamin substances landscaping as it is growing more and more popular with the global community. People who are aware of the healthy way of tom revealing vegan habits are using those who can take plant-based omega-3 dietary supplements. According to Shanna Peevey, the director of consumer research, some sevenfold increase in people's interest in veganism has been registered during the last five to six years.

World Health Organization report points out that the number of people aged 60 and above will more than double between the 2015-2050 periods which was 12% at the beginning to 22% at the end. While older people can sometimes have depressive disorders, they tend to develop more memory loss, for example, Alzheimer's, migraine, Parkinson's, insomnia, and other conditions associated with the brain cells. Alzheimer's consists of diverse symptoms such as memory loss and speech impairment.

Key Insights

During the projection period, the herbal extracts category is projected to advance at 8.7% CAGR.

Comprises ingredients such as ginkgo biloba, curcumin, ginseng, and green tea extract.

Improves memory, brain blood flow, and cognitive function, and decreases mental fatigue.

Increasing need in emerging nations such as China and India for herbal items.

Ancient Chinese medication supplements are also marketed in Western markets.

Vitamins and minerals category to grow significantly, vital for brain function.

Offers B1, B2, B9, omega-3, necessary for neural function, headache reduction, brain wellness, and mood. Usually added into multivitamins.

The natural molecules category stood second in 2023 with 55% of the global revenue generated.

The rising demand for non-synthetic supplements compares with synthetic ones.

Companies are oriented towards natural ingredients embedded into products as a result of consumer pressure.

In 2023, the memory enhancement category generated the largest revenue share of around 30%.

The cause of this alarming rise is more susceptibility to mental health, such as dementia and Alzheimer's disease.

WHO reports that one in every four people has dementia, which is projected to reach 78 million by 2030.

The category Stress & anxiety that is the second fastest growing is the second

The statistical figure almost 3 out of 10 aged 13 to 18 will be diagnosed with an anxiety disorder.

The expected compound growth rate for depression and mood disorders is 8.9% in 2023.

A greater number of cases of depression, in particular vulnerable elders.

In 2023, the North American region had a 50% industry share because of growing cognitive health concerns and a robust sports sector.

Europe anticipates significant growth driven by mental well-being awareness and rising Alzheimer's cases.

APAC expects over 9.0% growth, led by concerns about brain health, stress, and education sector demand.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by product
  • 1.4.2. Market size breakdown, by application
  • 1.4.3. Market size breakdown, by region
  • 1.4.4. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Revenue, by Product (2017-2030)
• 6.3. Market Revenue, by Application (2017-2030)
• 6.4. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Revenue, by Product (2017-2030)
• 7.3. Market Revenue, by Application (2017-2030)
• 7.4. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Revenue, by Product (2017-2030)
• 8.3. Market Revenue, by Application (2017-2030)
• 8.4. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Revenue, by Product (2017-2030)
• 9.3. Market Revenue, by Application (2017-2030)
• 9.4. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Revenue, by Product (2017-2030)
• 10.3. Market Revenue, by Application (2017-2030)
• 10.4. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Revenue, by Product (2017-2030)
• 11.3. Market Revenue, by Application (2017-2030)
• 11.4. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Revenue, by Product (2017-2030)
• 12.3. Market Revenue, by Application (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Revenue, by Product (2017-2030)
• 13.3. Market Revenue, by Application (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Revenue, by Product (2017-2030)
• 14.3. Market Revenue, by Application (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Revenue, by Product (2017-2030)
• 15.3. Market Revenue, by Application (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Revenue, by Product (2017-2030)
• 16.3. Market Revenue, by Application (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Revenue, by Product (2017-2030)
• 17.3. Market Revenue, by Application (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Revenue, by Product (2017-2030)
• 18.3. Market Revenue, by Application (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Revenue, by Product (2017-2030)
• 19.3. Market Revenue, by Application (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Revenue, by Product (2017-2030)
• 20.3. Market Revenue, by Application (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Revenue, by Product (2017-2030)
• 21.3. Market Revenue, by Application (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Revenue, by Product (2017-2030)
• 22.3. Market Revenue, by Application (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Revenue, by Product (2017-2030)
• 23.3. Market Revenue, by Application (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Revenue, by Product (2017-2030)
• 24.3. Market Revenue, by Application (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Revenue, by Product (2017-2030)
• 25.3. Market Revenue, by Application (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Revenue, by Product (2017-2030)
• 26.3. Market Revenue, by Application (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Revenue, by Product (2017-2030)
• 27.3. Market Revenue, by Application (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Revenue, by Product (2017-2030)
• 28.3. Market Revenue, by Application (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. AlternaScript LLC
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. Natrol LLC
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. Health Via Modern Nutrition Inc.
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. KeyView Labs Inc.
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. Natural Factors Nutritional Products Ltd.
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. Onnit Labs Inc.
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. Peak Nootropics LLC
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary
• 30.8. Purelife Bioscience Co. Ltd.
  • 30.8.1. Business overview
  • 30.8.2. Product and service offerings
  • 30.8.3. Key financial summary
• 30.9. Intelligent Labs
  • 30.9.1. Business overview
  • 30.9.2. Product and service offerings
  • 30.9.3. Key financial summary
• 30.10. Accelerated Intelligence Inc.
  • 30.10.1. Business overview
  • 30.10.2. Product and service offerings
  • 30.10.3. Key financial summary
• 30.11. NOW Foods
  • 30.11.1. Business overview
  • 30.11.2. Product and service offerings
  • 30.11.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports